Drugs / Stable isotope tracer (13-C(4)-BHB)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00860392 | Mar → Jul 2009 | diabetes mellitus | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Stable isotope tracer (13-C(4)-BHB) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00860392 ↗ |
| Route | Intravenous | “will be administered intravenously” NCT00860392 ↗ |